NIH grants infrastructure awards for human embryonic stem cell research

April 26, 2002

Bethesda, Maryland -- The National Institutes of Health announced today the granting of four resource infrastructure enhancement awards for human embryonic stem cell (hESC) research.

These awards will stimulate the use of hESC in basic research by providing funds for expansion, testing, quality assurance, and distribution of existing cell lines that meet the President's criteria for federal funding of research on hESC.

The four entities to receive the awards include Cellsaurus, a subsidiary of Bresagen, of Athens, Georgia; ES Cell International Pte Ltd, of Melbourne, Victoria, Australia; the University of California, San Francisco, California; and the Wisconsin Alumni Research Foundation of Madison, Wisconsin.

"These awards represent the first major expenditure by the NIH for supporting human embryonic stem cell research," said Ruth Kirschstein, M.D., Acting NIH Director. "By providing these funds, the NIH is hoping to get these cells into the hands of basic scientists as quickly as possible."

The four entities are listed on the NIH Human Embryonic Stem Cell Registry, http://escr.nih.gov and have a combined total of 17 stem cell lines that will be available to basic scientists for research. These awards provide a total of approximately $3.5 million over two years. NIH sponsors of the awards include the National Center for Research Resources (NCRR); the National Heart, Lung, and Blood Institute (NHLBI); the National Institute of Aging (NIA); The National Institute of Child Health and Human Development (NICHD); the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); and the National Institute of Mental Health (NIMH).

A stem cell is a special kind of cell that has a unique capacity to renew itself and to give rise to specialized cell types. Although most cells of the body, such as heart cells or skin cells, are committed to conduct a specific function, a stem cell is uncommitted and remains uncommitted, until it receives a signal to develop into a specialized cell. Researchers hope that the study of hESC will lead to a better understanding of cell function, cell differentiation, and human development.

BresaGen, Ltd. is an Australian biotechnology company committed to the discovery and commercial development of innovative biotherapies. During two decades of experience, the company has been involved in reproductive and developmental biology and in the manufacture of recombinant protein pharmaceuticals. Its U.S. subsidiary, BresaGen, Inc. is located in Athens, Georgia.

ES Cell International is a regenerative medicine company focusing on developing therapeutic products from human embryonic stem (hES) cells. ES Cell International was incorporated in Singapore in July 2000. Its corporate headquarters, together with a dedicated research and production facility, are housed within a leading Australian Medical Research Precinct. ES Cell International funds research collaborations with the Monash Institute of Reproduction and Development (Australia), the National University of Singapore (Singapore), Hadassah Medical Organisation (Israel), and the Hubrecht Laboratory (the Netherlands).

University of California, San Francisco is one of the country's leading health sciences institutions. UCSF is dedicated to scientific research, graduate education and patient care. Three UCSF scientists have been named Nobel laureates in the last 10 years.

The WiCell Research Institute, Inc., is a non-profit institution established in 1999 to advance research in the area of stem cells. It has a license from the Wisconsin Alumni Research Foundation (WARF) to distribute stem cells. WARF, founded in 1925, patents research discoveries at the University of Wisconsin, Madison. The National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services, funded primate research studies at the University of Wisconsin, Madison, that led to certain discoveries claimed in Wisconsin patent rights.

The National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services, is the premier federal agency for biomedical research.
-end-


NIH/National Institutes of Health

Related Stem Cells Articles from Brightsurf:

SUTD researchers create heart cells from stem cells using 3D printing
SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.

More selective elimination of leukemia stem cells and blood stem cells
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.

Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.

First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.

Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.

The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.

Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.

New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.

NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.

Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.

Read More: Stem Cells News and Stem Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.